Although we showed that HDAC2 inhibitors obtained good results in inhibiting tumor growth in cell and animal experiments, HDAC2 is highly homologous to HDAC8, which might result in unexpected side effects due to the paninhibition of HDAC [49]. Here, HDAC8 is linked to neoplasm.